Investigating the impact of oral probiotic supplementation for acne management
In our previous double-blind randomized placebo-controlled clinical study (2022) involving eighty Caucasian adult subjects, we tested the efficacy of an oral probiotic formulation (Lactiplantibacillus plantarum PBS067, Lacticaseibacillus rhamnosus LRH020, and Limosilactobacillus reuteri PBS072) in ameliorating AV (Acne Vulgaris) clinical signs (smoothness and moisturization) and decreasing the levels of skin inflammatory markers.
These strains successfully colonized the gastrointestinal tract and exerted long-term effects.This new clinical trial by Complife, aims to assess the efficacy of the same specific probiotic strain composition in the improvement of Acne status in a population of adult women of the APAC region.The study was conducted in our lab at Complife Beijing Testing Technology Ldt facilities (Beijing, China).
Up-to date with Asian innovations!
Complife Beijing has two locations in China: a complete and innovative safety & efficacy IN VIVO lab with local personnel and a commercial office with a great technical and regulatory expertise.
Complife Beijing is committed to ensure the highest standards of service quality in the Asian continent.
